One in four US adults with diabetes used a GLP-1 drug last year, survey finds
The wildly popular and effective GLP-1 drugs Mounjaro from Eli Lilly (LLY.N), opens new tab and Ozempic from Novo Nordisk (NOVOb.CO), opens new tab are approved in the United States for treating type 2 diabetes. They are sold as Zepbound and Wegovy, respectively, for weight loss and are being tested for other conditions.
Use of the injectable drugs was highest among adults with diabetes aged 50–64 at 33.3%, reflecting the more significant disease burden in this group, the report said.
A quarter or 25.3% of adults with diabetes aged 18 to 34 reported using a GLP-1 drug, while the adoption rate was 20.8% among those 65 and older.
The data are from a nationally representative annual survey of U.S. adults aged 18 and older that was conducted in person and with follow-up by phone in 2024.
In 2024, for the first time, participants in the annual survey who had diabetes were asked if they were using the Lilly or Novo blockbusters or other GLP-1 drugs to lower blood sugar or lose weight.
The drugs mimic the activity of a hormone that regulates blood sugar levels, slows digestion and helps people feel full for longer.
Drugmakers Lilly and Novo have faced criticism about the cost of the treatments, which carry a list price of about $1,000 for a month's supply.
Roughly 31% of survey participants who reported using insulin also reported using GLP-1 drugs, as did about 28% of patients who were using oral drugs to control their blood sugar, according to the report, indicating that these treatments are being integrated into combination regimens.
Hispanic adults with diabetes had the highest rate of GLP-1 use, at 31.3%, followed by Black non-Hispanic and White non-Hispanic adults, at 26.5% and 26.2%, respectively, the survey found.
Only 12.1% of Asian non-Hispanic adults with diabetes used the drugs, which may reflect disparities in access or adoption of the therapies.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
15 minutes ago
- Reuters
US health department reinstates task force on safer childhood vaccines
Aug 14 (Reuters) - The U.S. Department of Health and Human Services said on Thursday it is reinstating its task force on a federal panel for safer childhood vaccines after 27 years. The panel was created by Congress to improve the safety, quality and oversight of vaccines administered to American children. The original task force was disbanded in 1998, said the health agency, adding that National Institutes of Health director Jay Bhattacharya will serve as chairman of the task force. The task force will work closely with the Advisory Commission on Childhood Vaccines, the HHS said.
The Independent
17 minutes ago
- The Independent
The big changes coming to these popular snacks next year
Mars Wrigley North America is set to remove artificial colours from several of its popular confectionery products in the United States from next year. The affected brands include M&M's Chocolate, Skittles Original, Extra Gum Spearmint, and Starburst Original fruit chews. This initiative aligns with the Trump administration's 'Make America Healthy Again' plan, which targets synthetic dyes in foods. The candy manufacturer quietly announced the change last month, confirming the products would be available online across the country. Mars Wrigley has indicated it will share further commitments and timelines for additional items once fully effective and scalable solutions are identified.
Reuters
17 minutes ago
- Reuters
Hack at UnitedHealth's tech unit impacted 192.7 million people, US health dept website shows
Aug 14 (Reuters) - The cyberattack at UnitedHealth Group's (UNH.N), opens new tab tech unit last year impacted 192.7 million people, the U.S. health department's website showed on Thursday. In January, the company had estimated the hack at Change Healthcare affected the personal information of 190 million people. The cyberattack — the largest healthcare data breach in the United States to date — was disclosed in February last year. The unit was infiltrated by hackers who identified themselves as the "Blackcat" ransomware group, causing widespread disruptions in claims processing and impacting patients and providers across the country. The number of impacted people was posted on a list of data breaches maintained by the U.S. Department of Health and Human Services' office for civil rights. UnitedHealth did not immediately respond to a Reuters request for comment. Information made vulnerable in the UnitedHealth attack is believed to include health insurance member IDs, patient diagnoses, treatment information and social security numbers, as well as billing codes used by providers.
